SEC Form 4 · Updated Daily

NTLA

— INTELLIA THERAPEUTICS, INC. Ownership

Insider and institutional ownership derived from SEC Form 4 filings. Click any owner to see their holdings across every company they’ve filed on, and how their position has changed over time.

Financials Ownership

Current Reporting Owners

Owner	Role	Shares Owned	As Of	Last Activity
Haurwitz Rachel E.	10%+ Owner · Director	5,593,846	2016-05-11	C
Caribou Therapeutics Holdco, LLC	10%+ Owner	5,593,846	2016-05-11	C
NOVARTIS AG	10%+ Owner	4,277,073	2018-03-16	—
Novartis Institutes for BioMedical Research, Inc.	10%+ Owner	4,277,073	2018-03-16	—
Caribou Biosciences, Inc.	10%+ Owner	3,994,355	2018-01-29	S
Atlas Venture Fund IX, L.P.	10%+ Owner	3,699,788	2017-07-07	S
Atlas Venture Associates IX, L.P.	10%+ Owner	3,699,788	2017-07-07	S
Atlas Venture Associates IX, LLC	10%+ Owner	3,699,788	2017-07-07	S
ORBIMED ADVISORS LLC	Director	2,662,180	2016-05-11	P
OrbiMed Capital GP V LLC	10%+ Owner	2,662,180	2016-05-11	P
ISALY SAMUEL D	10%+ Owner	2,662,180	2016-05-11	P
OrbiMed Global Healthcare GP LLC	Director	2,662,180	2016-05-11	P
GORDON CARL L	Director	2,662,180	2016-05-11	P
LEONARD JOHN M	Director · Officer	1,149,849	2026-08-20	S
BAKER FELIX	10%+ Owner · Director	976,214	2016-05-11	P
BAKER JULIAN	10%+ Owner · Director	976,214	2016-05-11	P
BAKER BROS. ADVISORS LP	10%+ Owner · Director	976,214	2016-05-11	P
Baker Bros. Advisors (GP) LLC	10%+ Owner · Director	976,214	2016-05-11	P
Temasek Holdings (Private) Ltd	10%+ Owner	790,527	2016-05-11	P
Temasek Life Sciences Private Ltd	10%+ Owner	790,527	2016-05-11	P
Fullerton Management Pte Ltd	10%+ Owner	790,527	2016-05-11	P
TLS Beta Pte. Ltd.	10%+ Owner	790,527	2016-05-11	P
Bermingham Nessan	Director · Officer	696,000	2017-12-06	S
Cohen Fred E	Director	216,653	2026-06-09	A
Rivera Jose E	Officer	178,077	2021-04-01	M
Barnes Thomas M.	Officer	174,807	2016-05-05	—
Morrissey David V	Officer	174,807	2016-05-05	—
Srivastava Sapna	Director	159,031	2016-05-05	—
BASTA JAMES	Officer	158,005	2026-03-01	A
Dulac Edward J III	Officer	148,175	2026-07-22	S
CHASE WILLIAM J	Director	143,893	2026-06-09	A
Schultes Birgit C	Officer	137,733	2026-03-01	A
Lebwohl David	Officer	131,192	2026-03-01	A
Clark Eliana	Officer	94,471	2026-03-01	A
KARSEN PERRY A	Director	93,764	2020-12-17	M
Sepp-Lorenzino Laura	Officer	77,388	2025-01-03	S
Goddard Glenn	Officer	69,213	2024-03-01	A
Dube Michael P	Officer	65,022	2026-10-02	S
Heifner Nicole	Officer	64,705	2016-05-05	—
Hicks Derek	Officer	59,878	2025-01-03	S
Keresty Georgia	Director	41,083	2026-06-09	A
Bhanji Muna	Director	36,403	2026-06-09	A
Verwiel Frank	Director	35,148	2026-06-09	A
GOODMAN JESSE	Director	33,559	2026-06-09	A
Goff Brian	Director	32,609	2026-06-09	A
Bell Graeme	Officer	21,400	2018-03-28	M
SCHIERMEIER ANDREW	Officer	18,033	2020-12-31	M
DORSA CAROLINE	Director	12,701	2022-06-14	A
Crowley John F	Director	11,716	2023-06-14	A
FORMELA JEAN FRANCOIS	Director	7,291	2022-06-14	A

Recent Filings

Date	Owner	Activity	Shares	Price	Owned After
2026-10-02	Dube Michael P	Open-market sale	1,864	$12.43	65,022
2026-08-21	LEONARD JOHN M	Open-market sale	2,785	$13.00	1,147,064
2026-08-20	LEONARD JOHN M	Open-market sale	19,890	$12.60	1,149,849
2026-07-22	Dulac Edward J III	Open-market sale	8,111	$11.25	148,175
2026-07-02	Dulac Edward J III	Open-market sale	4,677	$18.00	156,286
2026-07-01	Dube Michael P	Open-market sale	2,641	$16.78	66,886
2026-06-09	Bhanji Muna	Grant / award (derivative)	13,300	$0.00	13,300
2026-06-09	Bhanji Muna	Grant / award	9,200	$0.00	36,403
2026-06-09	CHASE WILLIAM J	Grant / award (derivative)	13,300	$0.00	13,300
2026-06-09	CHASE WILLIAM J	Grant / award	9,200	$0.00	143,893
2026-06-09	Cohen Fred E	Grant / award (derivative)	13,300	$0.00	13,300
2026-06-09	Cohen Fred E	Grant / award	9,200	$0.00	216,653
2026-06-09	Goff Brian	Grant / award (derivative)	13,300	$0.00	13,300
2026-06-09	Goff Brian	Grant / award	9,200	$0.00	32,609
2026-06-09	GOODMAN JESSE	Grant / award (derivative)	13,300	$0.00	13,300
2026-06-09	GOODMAN JESSE	Grant / award	9,200	$0.00	33,559
2026-06-09	Keresty Georgia	Grant / award (derivative)	13,300	$0.00	13,300
2026-06-09	Keresty Georgia	Grant / award	9,200	$0.00	41,083
2026-06-09	Verwiel Frank	Grant / award (derivative)	13,300	$0.00	13,300
2026-06-09	Verwiel Frank	Grant / award	9,200	$0.00	35,148
2026-03-02	Clark Eliana	Open-market sale	607	$13.78	93,864
2026-03-02	BASTA JAMES	Open-market sale	1,211	$13.78	156,794
2026-03-01	Dube Michael P	Grant / award	17,250	$0.00	69,527
2026-03-01	Clark Eliana	Grant / award (derivative)	10,505	$0.00	10,505
2026-03-01	Clark Eliana	Grant / award	7,353	$0.00	94,471
2026-03-01	Schultes Birgit C	Grant / award (derivative)	56,000	$0.00	56,000
2026-03-01	Schultes Birgit C	Grant / award	39,200	$0.00	137,733
2026-03-01	Dulac Edward J III	Grant / award (derivative)	87,543	$0.00	87,543
2026-03-01	Dulac Edward J III	Grant / award	61,280	$0.00	160,963
2026-03-01	Lebwohl David	Grant / award (derivative)	14,204	$0.00	14,204
2026-03-01	Lebwohl David	Grant / award	9,943	$0.00	131,192
2026-03-01	BASTA JAMES	Grant / award (derivative)	65,829	$0.00	65,829
2026-03-01	BASTA JAMES	Grant / award	46,080	$0.00	158,005
2026-03-01	LEONARD JOHN M	Grant / award (derivative)	225,400	$0.00	225,400
2026-03-01	LEONARD JOHN M	Grant / award	156,400	$0.00	1,169,739
2026-01-05	Dube Michael P	Open-market sale	2,989	$9.21	52,277
2026-01-05	Dulac Edward J III	Open-market sale	6,379	$9.21	99,683
2026-01-05	Clark Eliana	Open-market sale	9,515	$9.21	87,118
2026-01-05	Lebwohl David	Open-market sale	11,903	$9.21	121,249
2026-01-05	Cohen Fred E	Open-market buy	150,000	$9.35	207,453

Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.